Literature DB >> 8259684

Analysis of the DNA-binding domain of the HSV-1 origin-binding protein.

D W Martin1, R M Muñoz, D Oliver, M A Subler, S Deb.   

Abstract

In order to understand DNA-protein interactions at the origin of DNA replication in herpes simplex virus type 1 (HSV-1), we have undertaken an analysis of the DNA-binding domain of the origin-binding protein (OBP) and its mechanism of binding to the Oris sequence of HSV-1. Mutant DNA-binding domains were constructed, expressed in vitro, and used to test for binding by gel shift analysis. A C-terminal deletion mutant was functional in binding, thereby redefining the C-terminal boundary of the DNA-binding domain at amino acid 822. Fifteen insertion mutants were also constructed across the DNA-binding domain. Several of these mutants were unable to bind DNA. Interestingly, 4 mutants that destroy DNA binding fall within a region that has a particularly high degree of sequence similarity to the varicella zoster virus gene 51 product. A second objective was to define how the DNA-binding domain interacts with the origin. Results of gel shift analysis using contranslated proteins of different sizes suggest that the DNA-binding domain can interact with a single binding site as a monomer. Binding to the wild-type Oris template indicated that the binding domains can interact with both binding sites I and II independent of any cooperative effect mediated by the amino-termini. This suggests that the basic unit of recognition involved in OBP/Oris interactions may contain a single DNA-binding domain of OBP in association with a single binding site.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8259684     DOI: 10.1006/viro.1994.1009

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  11 in total

1.  Properties of the novel herpes simplex virus type 1 origin binding protein, OBPC.

Authors:  K Baradaran; M A Hardwicke; C E Dabrowski; P A Schaffer
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

2.  Functional characterization of Marek's disease virus (MDV) origin-binding protein (OBP): analysis of its origin-binding properties.

Authors:  T F Wu; H H Chen; H Wu
Journal:  Virus Genes       Date:  2001       Impact factor: 2.332

3.  Strain-dependent differences in the human cytomegalovirus replication origin.

Authors:  Z Chen; S Watanabe; N Yamaguchi
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

4.  Cloning and sequence analysis of a Marek's disease virus origin binding protein (OBP) reveals strict conservation of structural motifs among OBPs of divergent alphaherpesviruses.

Authors:  T F Wu; W Sun; M Boussaha; R Southwick; P M Coussens
Journal:  Virus Genes       Date:  1996       Impact factor: 2.332

5.  Expression of the varicella-zoster virus origin-binding protein and analysis of its site-specific DNA-binding properties.

Authors:  D Chen; P D Olivo
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

6.  Transcriptional analysis of the region of the herpes simplex virus type 1 genome containing the UL8, UL9, and UL10 genes and identification of a novel delayed-early gene product, OBPC.

Authors:  K Baradaran; C E Dabrowski; P A Schaffer
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

7.  Stepwise evolution of the herpes simplex virus origin binding protein and origin of replication.

Authors:  Monica Olsson; Ka-Wei Tang; Cecilia Persson; L Marcus Wilhelmsson; Martin Billeter; Per Elias
Journal:  J Biol Chem       Date:  2009-04-07       Impact factor: 5.157

8.  Varicella-zoster virus gene 51 complements a herpes simplex virus type 1 UL9 null mutant.

Authors:  D Chen; E C Stabell; P D Olivo
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

9.  Human herpesvirus 6B origin-binding protein: DNA-binding domain and consensus binding sequence.

Authors:  N Inoue; P E Pellett
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

10.  Effective treatment of respiratory alphaherpesvirus infection using RNA interference.

Authors:  Amy Fulton; Sarah T Peters; Gillian A Perkins; Keith W Jarosinski; Armando Damiani; Margaret Brosnahan; Elizabeth L Buckles; Nikolaus Osterrieder; Gerlinde R Van de Walle
Journal:  PLoS One       Date:  2009-01-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.